ARS Pharmaceuticals, Inc. (SPRY)
3.535
-0.12
(-3.15%)
USD |
NASDAQ |
Nov 18, 10:34
ARS Pharmaceuticals Price : 3.535 for Nov. 18, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 17, 2026 | 3.51 | 3.785 | 3.51 | 3.65 | 1.192M |
| Nov 16, 2026 | 3.85 | 4.00 | 3.59 | 3.59 | 3.285M |
| Nov 13, 2026 | 3.86 | 3.995 | 3.79 | 3.89 | 1.297M |
| Nov 12, 2026 | 3.90 | 4.106 | 3.795 | 3.81 | 2.289M |
| Nov 11, 2026 | 3.57 | 4.13 | 3.57 | 3.95 | 3.846M |
| Nov 10, 2026 | 3.15 | 3.74 | 3.07 | 3.57 | 2.905M |
| Nov 09, 2026 | 2.80 | 3.17 | 2.73 | 3.15 | 3.187M |
| Nov 06, 2026 | 2.66 | 2.84 | 2.44 | 2.79 | 5.673M |
| Nov 05, 2026 | 3.05 | 3.095 | 2.59 | 2.65 | 2.773M |
| Nov 04, 2026 | 3.13 | 3.225 | 2.995 | 3.05 | 2.494M |
| Nov 03, 2026 | 3.05 | 3.11 | 2.92 | 3.05 | 2.422M |
| Nov 02, 2026 | 3.40 | 3.49 | 2.91 | 3.05 | 2.129M |
| Oct 30, 2026 | 3.62 | 3.79 | 3.34 | 3.38 | 1.757M |
| Oct 29, 2026 | 3.70 | 3.90 | 3.625 | 3.66 | 2.044M |
| Oct 28, 2026 | 3.69 | 3.73 | 3.525 | 3.65 | 2.535M |
| Oct 27, 2026 | 3.92 | 3.95 | 3.64 | 3.73 | 1.644M |
| Oct 26, 2026 | 4.03 | 4.09 | 3.90 | 3.92 | 1.434M |
| Oct 23, 2026 | 4.28 | 4.28 | 3.995 | 4.03 | 1.522M |
| Oct 22, 2026 | 4.13 | 4.355 | 4.13 | 4.32 | 1.788M |
| Oct 21, 2026 | 4.32 | 4.42 | 4.165 | 4.18 | 1.011M |
| Oct 20, 2026 | 4.25 | 4.44 | 4.225 | 4.29 | 1.543M |
| Oct 19, 2026 | 4.07 | 4.32 | 4.00 | 4.23 | 1.509M |
| Oct 16, 2026 | 4.08 | 4.08 | 3.810 | 4.02 | 2.332M |
| Oct 15, 2026 | 3.99 | 4.095 | 3.94 | 4.07 | 2.220M |
| Oct 14, 2026 | 4.01 | 4.095 | 3.885 | 3.93 | 1.730M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Capricor Therapeutics, Inc. | 8.94 |
| Sionna Therapeutics, Inc. | 3.06 |
| Ardelyx, Inc. | 3.19 |
| Zentalis Pharmaceuticals, Inc. | 1.44 |
| Compass Therapeutics, Inc. | 0.6094 |
Price Related Metrics
| PS Ratio | 2.875 |
| PEG Ratio | -0.0118 |
| Earnings Yield | -56.93% |
| Market Cap | 354.38M |
| PEGY Ratio | -0.0118 |